Also Cyp has treated 165 patients in Osteoarthritis without generating an adverse event worthy of reporting. And these 165 patients received multiple injections. So we’re looking at close to 400 doses of Cymerus cells without triggering an event that would halt recruitment.
- Forums
- ASX - By Stock
- Ann: Encouraging Initial Data from CYP-006TK DFU Trial
Also Cyp has treated 165 patients in Osteoarthritis without...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 18.5¢ | $58.84K | 310.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 33236 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 163350 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 33236 | 0.185 |
4 | 67678 | 0.180 |
2 | 3285 | 0.175 |
3 | 34148 | 0.170 |
2 | 25050 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 163350 | 1 |
0.200 | 38789 | 3 |
0.210 | 65390 | 2 |
0.250 | 12872 | 1 |
0.255 | 15000 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online